NCT05266027View on ClinicalTrials.gov

Naldebain for Pain Management After Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 6, 2022

Primary Completion Date

November 28, 2022

Study Completion Date

November 28, 2022

Conditions
Arthropathy of Knee Joint
Interventions
DRUG

Nalbuphine Sebacate (Naldebain)

Nalbuphine Sebacate (Naldebain) 2mL/150mg would be intramuscularly injected during knee arthroplasty surgery.

DRUG

Placebo medication

Placebo medication, Nalbuphine Sebacate not contained

Trial Locations (1)

807

Kaohsiung Medical University Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER